A. Noë

Membrane Immunoglobulin Is Associated with a Phosphoprotein Complex

M. Newell, M. Julius, A. Noë, 1989 .

Identification of a 116 kDa protein able to bind 1,3-bis(2-chloroethyl)-1-nitrosourea-damaged DNA as poly(ADP-ribose) polymerase.

N. Berger, G. Poirier, L. Panasci, 1996, Mutation research.

SarCNU (2-chloroethyl-3-sarcosinamide-1-nitrosourea): a novel analogue of chloroethylnitrosourea that is transported by the catecholamine uptake2 carrier, which mediates increased cytotoxicity

L. Panasci, A. Noë, D. Marcantonio, 1996, Cancer Chemotherapy and Pharmacology.

Characterization of the catecholamine extraneuronal uptake2 carrier in human glioma cell lines SK-MG-1 and SKI-1 in relation to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) selective cytotoxicity.

L. Panasci, A. Malapetsa, A. Noë, 1996, Biochemical pharmacology.

Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kinetics.

L. Panasci, A. Malapetsa, A. Noë, 1994, Cancer research.

Poly(ADP-ribose) polymerase can bind melphalan damaged DNA.

G. Poirier, L. Panasci, J. Bramson, 1993, Cancer research.

Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system.

L. Panasci, A. Malapetsa, A. Noë, 1993, Molecular pharmacology.

Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblasts

L. Panasci, J. Bramson, A. Malapetsa, 2004, Cancer Chemotherapy and Pharmacology.